Tower Research Capital LLC (TRC) - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R300. A total of 58 filers reported holding PLURISTEM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$1,000
-94.4%
582
-83.9%
0.00%
Q1 2021$18,000
+157.1%
3,618
+329.7%
0.00%
Q2 2020$7,000
+16.7%
842
-44.2%
0.00%
Q1 2020$6,000
+100.0%
1,509
+92.5%
0.00%
Q3 2019$3,0007840.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
NIA IMPACT ADVISORS, LLC 837,898$1,734,0000.84%
Green Alpha Advisors, LLC 78,159$162,0000.11%
Values First Advisors, Inc. 49,485$102,0000.06%
SHELTON CAPITAL MANAGEMENT 128,532$266,0000.01%
Archford Capital Strategies, LLC 13,091$29,0000.01%
MEITAV INVESTMENT HOUSE LTD 167,593$347,0000.01%
Halpern Financial, Inc. 5,800$12,0060.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 70,000$145,0000.00%
TOWNSQUARE CAPITAL LLC 23,938$50,0000.00%
Newbridge Financial Services Group, Inc. 1,200$2,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders